Article Figures & Data
Tables
Administered activity (intravenous) Upper large intestine (organ receiving largest radiation dose) Effective dose Upper large intestine (organ receiving largest radiation dose) Effective dose Radiopharmaceutical MBq mCi mGy/MBq rad/mCi mSv/MBq rem/mCi mGy rad mSv rem 99mTc-pertechnetate 296–444 8–12 0.057 0.21 0.013 0.048 17–25 1.7–2.5 3.8–5.7 0.38–0.57 Data are from ICRP publication 53, page 199, no blocking agent (34).
Administered activity (intravenous) Upper large intestine (organ receiving largest radiation dose) Effective dose Upper large intestine (organ receiving largest radiation dose) Effective dose Radiopharmaceutical MBq mCi mGy/MBq rad/mCi mSv/MBq rem/mCi mGy rad mSv rem 99mTc-pertechnetate 37 (1.85 MBq/kg*) 1 (0.05 mCi/kg*) 0.20 0. 74 0.040 0.16 7.4 0.74 1.6 0.16 ↵* 20-kg body mass assumed.
Data are from ICRP publication 80, page 73, no blocking agent (35). Pediatric radiopharmaceutical administered dose is from 2010 North American consensus guidelines (16). EANM pediatric dose card (2007 version) may also be used (17).
Fetal dose Stage of gestation mGy/MBq rad/mCi Early 0.011 0.041 3 mo 0.022 0.081 6 mo 0.014 0.052 9 mo 0.0093 0.034 Data are from Russell et al. (32)
Jump to section
- Article
- PREAMBLE
- I. INTRODUCTION
- II. GOALS
- III. DEFINITIONS
- IV. COMMON CLINICAL INDICATIONS
- V. QUALIFICATIONS AND RESPONSIBILITES OF PERSONNEL (IN THE UNITED STATES)
- VI. PROCEDURE/SPECIFICATIONS OF THE EXAMINATION
- VII. DOCUMENTATION/REPORTING
- VIII. EQUIPMENT SPECIFICATION
- IX. QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION CONCERNS
- X. RADIATION SAFETY IN IMAGING
- XI. APPENDIX A: PHARMACOLOGIC PRETREATMENT IN CHILDREN REFERRED FOR MECKEL SCAN
- Acknowledgments
- XIV. APPROVAL
- Footnotes
- XII. REFERENCES
- Figures & Data
- Info & Metrics